FOR IMMEDIATE RELEASE
Contact:
Jennifer Hodorowicz
Marketing Communications Manager
919-334-6000
eCast Launches CT Select to Change Patient Selection for Clinical Trials
Raleigh, NC (June 2008) - Developed by eCast Corporation, CT Select uses emerging data sources, including electronic medical records and practice management data, along with lab and medication data to select highly targeted candidates that match trial protocols.
The results equate to proven enrollment, saving time and potentially millions of dollars during a product’s life cycle. These emerging data sources help populate the company’s clinical data repository (CDR), which is a robust, content-rich source of HIPAA-compliant, deidentified
patient data. It can be accessed for the rapid identification of specific research populations and their locations within the CT Select network of investigators. The CDR receives data from numerous sources resulting in a comprehensive collection of information that can be used to identify specific patient types as defined by the inclusion/exclusion criteria in a clinical protocol.
“We have access to HIPAA-secure CDR data,” says Peter Bechtel, president and CEO of eCast. “We only use it for inclusion/exclusion criteria for our CRO and pharma customers. The data that come into the CDR come from the EMR. We supply the EMR as part of this system, so that we get the highest quality data possible.”
When a clinical trial is placed with CT Select, eCast identifies the most qualified research sites across multiple therapeutic areas from within its site network. With a site network representing hundreds of trained and credentialed research investigators throughout the United States and Europe, CT Select is able to rapidly target the most qualified research subjects for clinical trials directly from the patient population within each practice.
For more information, visit or stop by Booth No. 811.
About eCast Corp.
eCast Corporation is an established medical software company based in Raleigh, NC with offices throughout the United States and Europe. Its flagship product, Pathways to Health, is an integrated delivery system for IPAs, PHOs, MSOs, and other provider networks. eCast also offers clinical integration and automation tools for physicians, such as eCast EMR and its proprietary eCast Risk Manager™ system for chronic disease prediction and management. The Company combines innovative technology with clinical research to empower doctors to participate as research investigators in clinical trials. In addition, eCast offers clinical research organizations and pharmaceutical companies a content-rich database of HIPAA secure trial candidates that can be rapidly filtered to specified inclusion and exclusion criteria.
For more information, visit
# # #